Lewis J. Stuart
Director/Board Member bei Linkage Biosciences, Inc.
Profil
Lewis J.
Stuart is currently a Director at Linkage Biosciences, Inc. He previously worked as Vice President-Sales at Agouron Pharmaceuticals LLC, Senior Vice President-Commercial Operations at CV Therapeutics, Inc., President & General Manager at Genetic Technologies Ltd., Vice President-Sales & Marketing at Genomic Health, Inc., and Chief Commercial Officer at NovaBay Pharmaceuticals, Inc. He also served as General Manager at Phenogen Sciences, Inc. Mr. Stuart received his undergraduate degree from Northeastern University and Virginia Polytechnic Institute & State University.
Aktive Positionen von Lewis J. Stuart
Unternehmen | Position | Beginn |
---|---|---|
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Lewis J. Stuart
Unternehmen | Position | Ende |
---|---|---|
CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | 29.12.2023 |
NOVABAY PHARMACEUTICALS | Corporate Officer/Principal | 23.07.2018 |
GENOMIC HEALTH, INC. | Sales & Marketing | 01.01.2017 |
GENETIC TECHNOLOGIES LIMITED | President | 01.01.2013 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | 02.05.2011 |
Ausbildung von Lewis J. Stuart
Northeastern University | Undergraduate Degree |
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENETIC TECHNOLOGIES LIMITED | Health Technology |
NOVABAY PHARMACEUTICALS | Health Technology |
Private Unternehmen | 6 |
---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | Health Technology |
Phenogen Sciences, Inc. |